(HOUSTON) – The Alliance for NanoHealth (ANH) recently provided the Texas A&M Health Science Center Institute of Biosciences and Technology with a $135,000 grant that will help in extending the capabilities of its Proteomics and Nanotechnology Laboratory for analyzing disease biomarkers and in collaborating with ANH investigators for nanotechnology applications.

Specifically, the grant will support the development of high throughput automated analysis of proteins by two-dimensional gel electrophoresis upstream of the HSC-IBT facility’s mass spectrometric units.

The grant was awarded as part of The Medical Nano Vector Research and Development Center of the Alliance for NanoHealth, an ANH program supported by the U.S. Department of the Army’s Telemedicine and Advanced Technology Research Center (TATRC). TATRC supports cutting-edge research and technology aimed at soldier health care.

Under the direction of Yongde Luo, Ph.D., the Proteomics and Nanotechnology Laboratory recently was established with support from the John S. Dunn Research Foundation. The facility is housed in the HSC-IBT Center for Cancer and Stem Cell Biology and supervised by director Wallace L. McKeehan, Ph.D., and Robert Schwartz, Ph.D., HSC-IBT director.

The Alliance for NanoHealth is a Texas Gulf Coast-based consortium of regional institutions, including the Texas A&M Health Science Center, aimed solely at using nanotechnology to bridge the gaps between medicine, biology, materials science, computer technology and public policy.

— Marketing & Communications